{"totalCount":2,"studies":[
{"protocolSection":{"identificationModule":{"nctId":"NCT06553768","orgStudyIdInfo":{"id":"MRX-802"},"secondaryIdInfos":[{"id":"2024-511287-85-00","type":"CTIS"}],"organization":{"fullName":"Mirum Pharmaceuticals, Inc.","class":"INDUSTRY"},"briefTitle":"Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)","officialTitle":"Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Participants With Cholestatic Pruritus"},"statusModule":{"statusVerifiedDate":"2026-01","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-10-14","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2026-10","type":"ESTIMATED"},"completionDateStruct":{"date":"2027-02","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-08-08","studyFirstSubmitQcDate":"2024-08-13","studyFirstPostDateStruct":{"date":"2024-08-14","type":"ACTUAL"},"lastUpdateSubmitDate":"2026-01-30","lastUpdatePostDateStruct":{"date":"2026-02-02","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Mirum Pharmaceuticals, Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this study is to determine whether the investigational treatment (maralixibat) is safe and effective in pediatric and adult participants who have cholestatic liver disease with pruritus that has been refractory to other therapies, and who have no other treatment options.","detailedDescription":"This study will be conducted in multiple sites in North America, Europe, Middle East and South America."},"conditionsModule":{"conditions":["Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)"],"keywords":["Pruritus","Cholestatic Liver Disease","Biliary Atresia"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":90,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Maralixibat","type":"EXPERIMENTAL","description":"Participants will receive maralixibat oral solution 300 μg/kg orally once daily for 1 week and then twice daily for 39 weeks.","interventionNames":["Drug: Maralixibat"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"Participants will receive placebo matched to maralixibat oral solution orally once daily for 1 week and then twice daily for 19 weeks. After 20 weeks, participants will receive maralixibat oral solution 300 μg/kg orally once daily for 1 week and then twice daily for 19 weeks.","interventionNames":["Other: Placebo"]}],"interventions":[{"type":"DRUG","name":"Maralixibat","description":"Maralixibat will be provided as an oral solution along with 0.5-, 1.0-, and 3.0-mL sized dosing dispensers. During the double-blind dose escalation period (4 weeks), the study drug (maralixibat) will be administered once daily for 1 week and then twice daily (BID; morning and evening). During the double-blind stable dosing period (16 weeks), participants will be treated with 300 μg/kg BID or the maximum tolerated dose (determined during the double-blind dose-escalation period) of maralixibat. During the open-label dose escalation period (4 weeks), all participants will receive maralixibat treatment once daily for 1 week and then twice daily (BID; morning and evening). During the open-label stable dosing period (at least 16 weeks), participants will be treated with 300 μg/kg BID or the maximum tolerated dose (determined during the open-label dose-escalation period) of maralixibat.","armGroupLabels":["Maralixibat"],"otherNames":["Formerly LUM001, SHP625"]},{"type":"OTHER","name":"Placebo","description":"Placebo matched to maralixibat will be provided as an oral solution along with 0.5-, 1.0-, and 3.0-mL sized dosing dispensers. During the double-blind dose escalation period (4 weeks), study drug will be administered once daily for 1 week and then twice daily (BID; morning and evening). During the double-blind stable dosing period (16 weeks), participants will be treated with 300 μg/kg BID or the maximum tolerated dose (determined during the double-blind dose-escalation period) of study drug. During the open-label dose escalation period (4 weeks), all participants will receive maralixibat treatment once daily for 1 week and then twice daily (BID; morning and evening). During the open-label stable dosing period (16 weeks), participants will be treated with 300 μg/kg BID or the maximum tolerated dose (determined during the open-label dose-escalation period) of maralixibat.","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Mean change in the ItchRO(Obs) severity score","description":"ItchRO(Obs) severity score = Itch Reported Outcome Observer assessment severity score; scale between 0 (not itchy at all) and 4 (extremely itchy); the lower the score the better.","timeFrame":"From baseline to average of week 13 to week 20"}],"secondaryOutcomes":[{"measure":"Mean change in total sBA (serum bile acid) level","timeFrame":"From baseline to average of week 12 and week 20"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Informed consent and assent (as applicable)\n2. Age ≥6 months at time of baseline visit\n3. Diagnosis of cholestatic liver disease with cholestatic pruritus based on the presence of chronic liver biochemical abnormalities (\\>90 days) and/or pathological evidence of progressive liver disease.\n4. If taking antipruritics or ursodeoxycholic acid, the participant has to be on a stable dosing regimen (i.e., same dose and frequency in the 30 days prior to the screening visit and will continue this dosing regimen up to Week 40 \\[adjustment for body weight is allowed\\]).\n5. Access to email or telephone for scheduled participant contacts and access to smart phone or tablet for PROs.\n6. Ability to read and/or understand the questionnaires (both caregivers and participants ≥9 years of age).\n7. For participants ≤18 years of age: Access to consistent caregiver(s) during the study.\n\nExclusion Criteria:\n\nThose who meet any of the following criteria are NOT eligible to participate in the study:\n\n1. Diagnosis of ALGS, ICP, PBC, PFIC, or PSC with native liver.\n2. Active atopic dermatitis or other non- cholestatic diseases associated with pruritus that are not controlled by standard treatment and that may interfere with the severity assessment of cholestasis-associated pruritus.\n3. Decompensated cirrhosis or complications of cirrhosis (e.g., esophageal or gastric variceal bleeding in the last 6 months, high-risk esophageal or gastric varices, ascites, hepatic encephalopathy, hepatorenal syndrome). Patients with compensated cirrhosis with preserved hepatic synthetic function and absence of complications are eligible.\n4. Suspected or proven cholangiocarcinoma or hepatocellular carcinoma.\n5. Unstable and/or serious medical disease that is likely to impair the ability to participate in all aspects of the study, confound efficacy and/or safety assessments, or result in substantially shortened life expectancy (e.g., any active malignancy including hematological malignancy, end-stage heart failure, active infection, acute and chronic diarrhea). Exceptionally, previous history of malignancy, adequately treated/in remission, that in opinion of investigator and medical monitor does not impact participant safety and participation in the study, may be allowed.\n6. Laboratory results during the screening visit as follows:\n\n   1. Platelet count ≤70,000/mm3. Patients with any condition that further increases bleeding risk are excluded.\n   2. Albumin \\<30 g/L\n   3. INR ≥1.5 (after intravenous or subcutaneous supplementation of vitamin K)\n   4. Total bilirubin \\>10 mg/dL\n   5. ALT \\>10× ULN\n7. Use of an IBAT inhibitor within 8 weeks prior to the screening visit.\n8. Known intolerance/hypersensitivity to maralixibat or its excipients.\n9. History of nonadherence to medical regimens, unreliability, medical condition, mental instability, or cognitive impairment that, in the opinion of the investigator, could compromise the validity of informed consent, compromise the safety of the participant, or lead to nonadherence with the study protocol or inability to conduct the study procedures.","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Months","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Clinical Trials Mirum","role":"CONTACT","phone":"+16506674085","email":"clinicaltrials@mirumpharma.com"},{"name":"Medinfo Mirum","role":"CONTACT","email":"medinfo@mirumpharma.com"}],"locations":[{"facility":"Children's Hospital Los Angeles (CHLA)","status":"RECRUITING","city":"Los Angeles","state":"California","zip":"90027","country":"United States","contacts":[{"name":"Siri Boonsawat","role":"CONTACT","phone":"323-361-4566","email":"sboonsawat@chla.usc.edu"},{"name":"Chuan-Hao Lin, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"Stanford Children's Health in Palo Alto","status":"RECRUITING","city":"Palo Alto","state":"California","zip":"94304","country":"United States","contacts":[{"name":"Yael Bichman","role":"CONTACT","email":"bichman@stanford.edu"},{"name":"Noelle Ebel, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":37.44188,"lon":-122.14302}},{"facility":"Lurie Children's Hospital","status":"RECRUITING","city":"Chicago","state":"Illinois","zip":"60611","country":"United States","contacts":[{"name":"Lee Bass, MD","role":"CONTACT"},{"name":"Lee Bass, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"Ochsner Clinic Foundation","status":"RECRUITING","city":"New Orleans","state":"Louisiana","zip":"70121","country":"United States","contacts":[{"name":"Shawan Stewart","role":"CONTACT","phone":"504-894-2873","email":"shawan.stewart@ochsner.org"},{"name":"Ryan Himes, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":29.95465,"lon":-90.07507}},{"facility":"NYU Langone Health","status":"RECRUITING","city":"New York","state":"New York","zip":"10016","country":"United States","contacts":[{"name":"Rozanne Groen","role":"CONTACT","phone":"646-754-2206","email":"rozanne.groen@nyulangone.org"},{"name":"Jennifer Vittorio, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Mount Sinai Hospital","status":"RECRUITING","city":"New York","state":"New York","zip":"10029","country":"United States","contacts":[{"name":"Jamie Chu, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Morgan Stanley Children's Hospital - NewYork Presbyterian","status":"RECRUITING","city":"New York","state":"New York","zip":"10032","country":"United States","contacts":[{"name":"Rachel Nuccitelli","role":"CONTACT","phone":"212-305-3839","email":"tcrcstudyreferral@cumc.columbia.edu"},{"name":"Mercedes Martinez, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Science 37, Inc (Remote-homebase Telemedicine)","status":"RECRUITING","city":"Morrisville","state":"North Carolina","zip":"27520","country":"United States","contacts":[{"name":"Clinical Research Coordinator","role":"CONTACT","phone":"984-355-0418","email":"EXPANDstudy@science37.com"}],"geoPoint":{"lat":35.82348,"lon":-78.82556}},{"facility":"Cincinnati Children's Hospital Medical Center","status":"RECRUITING","city":"Cincinnati","state":"Ohio","zip":"45229","country":"United States","contacts":[{"name":"Alexander Miethke, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":39.12711,"lon":-84.51439}},{"facility":"Children's Hospital of Philadelphia","status":"RECRUITING","city":"Philadelphia","state":"Pennsylvania","zip":"19104","country":"United States","contacts":[{"name":"Iraklis Petrof","role":"CONTACT","phone":"267-426-0970","email":"petrofi@chop.edu"},{"name":"Kathy Loomes, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":39.95238,"lon":-75.16362}},{"facility":"Vanderbilt University Medical Center","status":"RECRUITING","city":"Nashville","state":"Tennessee","zip":"37232","country":"United States","contacts":[{"name":"Saeed Mohammad, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"Baylor College of Medicine","status":"RECRUITING","city":"Houston","state":"Texas","zip":"77030","country":"United States","contacts":[{"role":"CONTACT","phone":"832-822-1343"},{"name":"Anna Banc-Husu, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"University of Utah","status":"RECRUITING","city":"Salt Lake City","state":"Utah","zip":"84112","country":"United States","contacts":[{"name":"Ann Rutherford","role":"CONTACT","phone":"801-585-9495","email":"ann.rutherford@hsc.utah.edu"},{"name":"Kyle Jensen, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":40.76078,"lon":-111.89105}},{"facility":"Seattle Children's Hospital","status":"RECRUITING","city":"Seattle","state":"Washington","zip":"98105","country":"United States","contacts":[{"name":"Contact GI Research","role":"CONTACT","phone":"206-987-2721","email":"GIResearch@seattlechildrens.org"},{"name":"Melissa Young","role":"CONTACT","phone":"206-987-1037","email":"Melissa.young@seattlechildrens.org"},{"name":"Pamela Valentino, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":47.60621,"lon":-122.33207}},{"facility":"Hospital de Criança de Brasília (HCB)","status":"RECRUITING","city":"Brasília","country":"Brazil","contacts":[{"name":"Elisa de Carvalho, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":-15.77972,"lon":-47.92972}},{"facility":"Hospital da Criança Santo Antonio","status":"RECRUITING","city":"Porto Alegre","country":"Brazil","contacts":[{"name":"Cristina Targa Ferreira, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":-30.03283,"lon":-51.23019}},{"facility":"Hospital Sírio-Libanês","status":"RECRUITING","city":"São Paulo","country":"Brazil","contacts":[{"name":"André Henrique Silva Lima","role":"CONTACT","phone":"+55 3391-5011","email":"andre.hlima@hsl.org.br"},{"name":"Gilda Porta, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"Stollery Children's Hospital","status":"RECRUITING","city":"Edmonton","state":"Alberta","zip":"T6G 2B7","country":"Canada","contacts":[{"name":"Susan Gilmour, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":53.55014,"lon":-113.46871}},{"facility":"Hôpital Femme Mère Enfant","status":"RECRUITING","city":"Lyon","country":"France","contacts":[{"name":"Mohammad Louay Alakhrass","role":"CONTACT","phone":"+33 4 72 68 13 43","email":"Mohammad.alakhrass@chu-lyon.fr"},{"name":"Matthias Ruiz, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":45.74906,"lon":4.84789}},{"facility":"Hôpitaux Universitaires de Marseille Timone","status":"RECRUITING","city":"Marseille","zip":"13005","country":"France","contacts":[{"name":"Bertrand Roquelaure, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":43.29695,"lon":5.38107}},{"facility":"Hôpital Kremlin Bicêtre","status":"RECRUITING","city":"Paris","country":"France","contacts":[{"name":"Hubert Lesur","role":"CONTACT","phone":"+33 145212968","email":"hubert.lesur-ext@aphp.fr"},{"name":"Emmanuel Gonzales, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"Universitätsklinikum Hamburg Eppendorf - Klinik für Kinder- und Jugendmedizin","status":"RECRUITING","city":"Hamburg","country":"Germany","contacts":[{"name":"Sebastian Schulz-Jürgensen, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"LMU Klinikum - Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital","status":"RECRUITING","city":"Munich","country":"Germany","contacts":[{"name":"Eberhart Lurz, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":48.13743,"lon":11.57549}},{"facility":"Azienda Ospedaliera Papa Giovanni XXIII","status":"RECRUITING","city":"Bergamo","zip":"24127","country":"Italy","contacts":[{"name":"Ester Benigno","role":"CONTACT","phone":"+39 352674311","email":"ebenigno@asst-pg23.it"},{"name":"Lorenzo D'Antiga, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":45.69601,"lon":9.66721}},{"facility":"ISMETT - Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione","status":"RECRUITING","city":"Palermo","zip":"90127","country":"Italy","contacts":[{"name":"Giovanna Lo Iacono","role":"CONTACT","phone":"+39 3346310393","email":"gloiacono@ismett.edu"},{"name":"Giusy Ranucci, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":38.1166,"lon":13.3636}},{"facility":"Ospedale Pediatrico Bambino Gesu","status":"RECRUITING","city":"Rome","zip":"00165","country":"Italy","contacts":[{"name":"Simona Donato","role":"CONTACT","phone":"+39 668597284","email":"simona.donato@opbg.net"},{"name":"Andrea Pietrobattista","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":41.89193,"lon":12.51133}},{"facility":"Hotel Dieu de France","status":"RECRUITING","city":"Beirut","country":"Lebanon","contacts":[{"name":"Adib Moukarzel, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":33.89332,"lon":35.50157}},{"facility":"Hospital Infantil de México Federico Gómez","status":"NOT_YET_RECRUITING","city":"Mexico City","country":"Mexico","contacts":[{"name":"Adriana Gómez Martínez, MD","role":"CONTACT","phone":"+52 5555783785","email":"adriana.gomezmtz@yahoo.com.mx"},{"name":"Alejandra Sánchez, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":19.42847,"lon":-99.12766}},{"facility":"Consultario de Joshue David Covarrubias Esquer","status":"NOT_YET_RECRUITING","city":"Zapopan","country":"Mexico","contacts":[{"name":"Krisztina Lévai","role":"CONTACT","phone":"+52 33 14711074","email":"krisztale@yahoo.co.uk"},{"name":"Joshue Covarrubias, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":20.72111,"lon":-103.38742}},{"facility":"Instytut Pomnik Centrum Zdrowia Dziecka","status":"RECRUITING","city":"Warsaw","country":"Poland","contacts":[{"name":"Magdalena Kozlowska","role":"CONTACT","phone":"+48.503.103.529","email":"m.kozlowska@ipczd.pl"},{"name":"Piotr Czubkowski, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":52.22977,"lon":21.01178}},{"facility":"King Faisal Specialist Hospital & Research Center","status":"RECRUITING","city":"Riyadh","zip":"12713","country":"Saudi Arabia","contacts":[{"name":"Mohammad Shagrani, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":24.68773,"lon":46.72185}},{"facility":"Hospital Sant Joan de Deu","status":"RECRUITING","city":"Barcelona","country":"Spain","contacts":[{"name":"Cristina Molera, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hospital Universitario Vall d'Hebron","status":"RECRUITING","city":"Barcelona","country":"Spain","contacts":[{"name":"Jesus Quintero, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hospital Universitario La Paz","status":"RECRUITING","city":"Madrid","country":"Spain","contacts":[{"name":"Esteban Frauca, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"King's College Hospital NHS Foundation Trust","status":"RECRUITING","city":"London","country":"United Kingdom","contacts":[{"name":"Katie Tupper","role":"CONTACT","phone":"+44 203-299-9841","email":"katietupper@nhs.net"},{"name":"Richard Thompson, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":51.50853,"lon":-0.12574}}]},"referencesModule":{"seeAlsoLinks":[{"label":"Mirum Pharmaceuticals homepage","url":"https://mirumpharma.com/"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-02-25"},"conditionBrowseModule":{"meshes":[{"id":"D015209","term":"Cholangitis, Sclerosing"},{"id":"D011537","term":"Pruritus"},{"id":"D001656","term":"Biliary Atresia"}],"ancestors":[{"id":"D002761","term":"Cholangitis"},{"id":"D001649","term":"Bile Duct Diseases"},{"id":"D001660","term":"Biliary Tract Diseases"},{"id":"D004066","term":"Digestive System Diseases"},{"id":"D012871","term":"Skin Diseases"},{"id":"D017437","term":"Skin and Connective Tissue Diseases"},{"id":"D012877","term":"Skin Manifestations"},{"id":"D012816","term":"Signs and Symptoms"},{"id":"D013568","term":"Pathological Conditions, Signs and Symptoms"},{"id":"D004065","term":"Digestive System Abnormalities"},{"id":"D000013","term":"Congenital Abnormalities"},{"id":"D009358","term":"Congenital, Hereditary, and Neonatal Diseases and Abnormalities"}]},"interventionBrowseModule":{"meshes":[{"id":"C000722912","term":"maralixibat"}]}},"hasResults":false},
{"protocolSection":{"identificationModule":{"nctId":"NCT04663308","orgStudyIdInfo":{"id":"VLX-301"},"secondaryIdInfos":[{"id":"2020-003027-41","type":"EUDRACT_NUMBER"},{"id":"2023-505764-11-00","type":"OTHER","domain":"EUCT number"}],"organization":{"fullName":"Mirum Pharmaceuticals, Inc.","class":"INDUSTRY"},"briefTitle":"A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)","officialTitle":"A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis","acronym":"VISTAS"},"statusModule":{"statusVerifiedDate":"2026-02","overallStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-12-18","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2026-06","type":"ESTIMATED"},"completionDateStruct":{"date":"2027-04","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-11-17","studyFirstSubmitQcDate":"2020-12-09","studyFirstPostDateStruct":{"date":"2020-12-11","type":"ACTUAL"},"lastUpdateSubmitDate":"2026-02-02","lastUpdatePostDateStruct":{"date":"2026-02-04","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Mirum Pharmaceuticals, Inc.","class":"INDUSTRY"}},"oversightModule":{"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC."},"conditionsModule":{"conditions":["Primary Sclerosing Cholangitis"],"keywords":["Pruritus","PSC","Itch","Itching","Cholestasis"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":182,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Part 1 Arm 1: Volixibat 20mg","type":"EXPERIMENTAL","description":"Participants randomized to this arm will receive volixibat 20mg twice daily.","interventionNames":["Drug: Volixibat"]},{"label":"Part 1 Arm 2: Volixibat 80mg","type":"EXPERIMENTAL","description":"Participants randomized to this arm will receive volixibat 80mg twice daily.","interventionNames":["Drug: Volixibat"]},{"label":"Part 1 Arm 3: Placebo","type":"PLACEBO_COMPARATOR","description":"Participants in this arm will receive capsules matched to the study drug minus the active volixibat substance, twice daily.","interventionNames":["Drug: Placebo"]},{"label":"Part 2 Arm 1: Volixibat Selected Dose 20mg","type":"EXPERIMENTAL","description":"Participants randomized to this arm will receive volixibat 20mg twice daily.","interventionNames":["Drug: Volixibat"]},{"label":"Part 2 Arm 2: Placebo","type":"PLACEBO_COMPARATOR","description":"Participants in this arm will receive capsules matched to the study drug minus the active volixibat substance, twice daily.","interventionNames":["Drug: Placebo"]}],"interventions":[{"type":"DRUG","name":"Volixibat","description":"Oral capsules, administered twice daily. Volixibat is an Ileal Bile Acid Transporter (IBAT) inhibitor.","armGroupLabels":["Part 1 Arm 1: Volixibat 20mg","Part 1 Arm 2: Volixibat 80mg","Part 2 Arm 1: Volixibat Selected Dose 20mg"],"otherNames":["SHP626"]},{"type":"DRUG","name":"Placebo","description":"Capsules matched to study drug minus active substance","armGroupLabels":["Part 1 Arm 3: Placebo","Part 2 Arm 2: Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Mean change in the daily itch scores using the Adult Itch Reported Outcome (Adult ItchRO) questionnaire","description":"The Adult ItchRO is an 11-point NRS measurement of itch severity ranging from 0=no itch to 10=worst possible itch.","timeFrame":"Baseline through to Week 28"}],"secondaryOutcomes":[{"measure":"Proportion of participants with itch response using the Adult ItchRO","timeFrame":"Baseline through to Week 28"},{"measure":"The incidence of adverse events","timeFrame":"Baseline through to Week 28"},{"measure":"Changes in serum bile acid levels","timeFrame":"Baseline through to Week 28"},{"measure":"Changes in alkaline phosphatase","timeFrame":"Baseline through to Week 28"},{"measure":"Changes in total bilirubin levels","timeFrame":"Baseline through to Week 28"},{"measure":"Change in Primary Sclerosing Cholangitis-Specific Patient-Reported Outcome","timeFrame":"Baseline through to Week 28"},{"measure":"Change in Patient-Reported Outcomes Measurement Information System (PROMIS®) fatigue questionnaire","description":"The PROMIS® Fatigue questionnaire is a 5-point response scale. Respondents endorse each item using a 5-point response scale: Never, Rarely, Sometimes, Often, and Always.","timeFrame":"Baseline through to Week 28"},{"measure":"Change in Patient-Reported Outcomes Measurement Information System (PROMIS®) sleep disturbance questionnaire","description":"The PROMIS® Sleep Disturbance in an 8-item measure that assesses quality of sleep, sleep depth, and restoration associated with sleep. It is a 5-point response scale, the specific response options vary by items. The first 4 items use response options that range from Not at all to Very much. The next 3 items use response options that range from Never to Always. The final item assesses sleep quality ranging from Very poor to Very good.","timeFrame":"Baseline through to Week 28"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Provide freely signed informed consent and assent (as applicable) and be willing to comply with all study visits and requirements through end of study, including the follow-up period.\n2. Subjects aged ≥12 years for eligible regions; otherwise ≥18 years\n3. Confirmed diagnosis of large duct or small duct PSC based on American Association for the Study of Liver Disease (AASLD) guidelines.\n4. Pruritus associated with PSC as assessed by Adult ItchRO.\n5. Ursodeoxycholic acid (UDCA) and anti-pruritic medication use will be allowed if meeting additional criteria.\n6. Concomitant Inflammatory Bowel Disease (IBD) is allowed if meeting additional criteria.\n\nExclusion Criteria:\n\n1. Pruritus associated with an etiology other than PSC\n2. Evidence or clinical suspicion of decompensated cirrhosis, or a history of decompensation events\n3. History of ileostomy or small bowel surgery/resection or other surgeries that may have disrupted the enterohepatic circulation\n4. Evidence, history, or suspicion of other liver disease; PSC patients with AIH are not excluded.\n5. Bile duct stent or percutaneous bile duct drain placement, or balloon dilatation procedure of a stricture within 12 weeks of Screening\n6. Exceeding pre-defined biochemical values for alanine aminotransferase/aspartate aminotransferase (ALT/AST), estimated glomerular filtration rate (eGFR),serum creatinine (sCr), platelet count, international normalized ratio (INR) and total bilirubin\n7. History of liver transplantation","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Southern California Research Center","city":"Coronado","state":"California","zip":"92118","country":"United States","geoPoint":{"lat":32.68589,"lon":-117.18309}},{"facility":"Cedars Sinai Medical Center","city":"Los Angeles","state":"California","zip":"90048","country":"United States","geoPoint":{"lat":34.05223,"lon":-118.24368}},{"facility":"University of California, Davis","city":"Sacramento","state":"California","zip":"95817","country":"United States","geoPoint":{"lat":38.58157,"lon":-121.4944}},{"facility":"California Pacific Medical Center Research Institute","city":"San Francisco","state":"California","zip":"94109","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"University of Colorado - Anschutz Medical Campus","city":"Aurora","state":"Colorado","zip":"80045","country":"United States","geoPoint":{"lat":39.72943,"lon":-104.83192}},{"facility":"MedStar Georgetown University Hospital","city":"Washington D.C.","state":"District of Columbia","zip":"20007","country":"United States","geoPoint":{"lat":38.89511,"lon":-77.03637}},{"facility":"Florida Research Institute","city":"Lakewood Rch","state":"Florida","zip":"34211","country":"United States","geoPoint":{"lat":27.3863,"lon":-82.4332}},{"facility":"University of Miami - Schiff Center for Liver Diseases","city":"Miami","state":"Florida","zip":"33136","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Tampa General Hospital","city":"Tampa","state":"Florida","zip":"33606","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"Beth Israel Deaconess Medical Center","city":"Boston","state":"Massachusetts","zip":"02215","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"Henry Ford Hospital","city":"Detroit","state":"Michigan","zip":"48202","country":"United States","geoPoint":{"lat":42.33143,"lon":-83.04575}},{"facility":"Mayo Clinic","city":"Rochester","state":"Minnesota","zip":"55905","country":"United States","geoPoint":{"lat":44.02163,"lon":-92.4699}},{"facility":"Southern Therapy and Advanced Research LLC","city":"Jackson","state":"Mississippi","zip":"39216","country":"United States","geoPoint":{"lat":32.29876,"lon":-90.18481}},{"facility":"Northwell Health","city":"Manhasset","state":"New York","zip":"11030","country":"United States","geoPoint":{"lat":40.79788,"lon":-73.69957}},{"facility":"New York University Langone Health","city":"New York","state":"New York","zip":"10016","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Weill Cornell Medical College","city":"New York","state":"New York","zip":"10021","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Columbia University Medical Center - Presbyterian Hospital and Vanderbilt Clinic","city":"New York","state":"New York","zip":"10032","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"University of Rochester Medical Center - Strong Memorial Hospital","city":"Rochester","state":"New York","zip":"14642","country":"United States","geoPoint":{"lat":43.15478,"lon":-77.61556}},{"facility":"Duke Health - Duke University Medical Center","city":"Durham","state":"North Carolina","zip":"27710","country":"United States","geoPoint":{"lat":35.99403,"lon":-78.89862}},{"facility":"Science 37, Inc (Remote-homebased Telemedicine)","city":"Morrisville","state":"North Carolina","zip":"27560","country":"United States","geoPoint":{"lat":35.82348,"lon":-78.82556}},{"facility":"Cleveland Clinic","city":"Cleveland","state":"Ohio","zip":"44195","country":"United States","geoPoint":{"lat":41.4995,"lon":-81.69541}},{"facility":"Einstein Healthcare Network - Einstein Medical Center","city":"Philadelphia","state":"Pennsylvania","zip":"19141","country":"United States","geoPoint":{"lat":39.95238,"lon":-75.16362}},{"facility":"University of Pittsburgh Medical Center","city":"Pittsburgh","state":"Pennsylvania","zip":"15213","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"Galen Medical Group","city":"Hixson","state":"Tennessee","zip":"37343","country":"United States","geoPoint":{"lat":35.14063,"lon":-85.23273}},{"facility":"Vanderbilt University Medical Center","city":"Nashville","state":"Tennessee","zip":"37232","country":"United States","geoPoint":{"lat":36.16589,"lon":-86.78444}},{"facility":"The Liver Institute At Methodist Dallas Medical Center","city":"Dallas","state":"Texas","zip":"75203","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"University of Texas Southwestern Medical Center","city":"Dallas","state":"Texas","zip":"75390","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"Houston Methodist Hospital","city":"Houston","state":"Texas","zip":"77030","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Liver Associates of Texas","city":"Houston","state":"Texas","zip":"77030","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"University of Utah Health Care","city":"Salt Lake City","state":"Utah","zip":"84132","country":"United States","geoPoint":{"lat":40.76078,"lon":-111.89105}},{"facility":"Bon Secours Liver Institution of Hampton Roads Mary Immaculate Hospital Office","city":"Newport News","state":"Virginia","zip":"23603","country":"United States","geoPoint":{"lat":36.98038,"lon":-76.42975}},{"facility":"Richmond Community Hospital LLC","city":"Richmond","state":"Virginia","zip":"23226","country":"United States","geoPoint":{"lat":37.55376,"lon":-77.46026}},{"facility":"University of Washington - Harborview Medical Center","city":"Seattle","state":"Washington","zip":"98104","country":"United States","geoPoint":{"lat":47.60621,"lon":-122.33207}},{"facility":"Liver Institute Northwest","city":"Seattle","state":"Washington","zip":"98105","country":"United States","geoPoint":{"lat":47.60621,"lon":-122.33207}},{"facility":"Hospital Italiano de Buenos Aires","city":"Buenos Aires","zip":"C1199","country":"Argentina","geoPoint":{"lat":-34.61315,"lon":-58.37723}},{"facility":"Glenny Corp S.A.","city":"Ciudad Autónoma Buenos Aires","zip":"C1430","country":"Argentina"},{"facility":"Hospital El Cruce","city":"San Juan Bautista","zip":"B1888","country":"Argentina","geoPoint":{"lat":-34.80896,"lon":-58.27623}},{"facility":"Royal Adelaide Hospital","city":"Adelaide","zip":"5000","country":"Australia","geoPoint":{"lat":-34.92866,"lon":138.59863}},{"facility":"Northern Health","city":"Epping","zip":"VIC 3076","country":"Australia","geoPoint":{"lat":-37.65,"lon":145.03333}},{"facility":"Liverpool Hospital","city":"Liverpool","zip":"2170","country":"Australia","geoPoint":{"lat":-33.91938,"lon":150.92588}},{"facility":"Austin Health","city":"Melbourne","zip":"3084","country":"Australia","geoPoint":{"lat":-37.814,"lon":144.96332}},{"facility":"University of the Sunshine Coast","city":"Sippy Downs","zip":"4556","country":"Australia","geoPoint":{"lat":-26.71793,"lon":153.05475}},{"facility":"Cliniques Universitaires Saint-Luc","city":"Brussels","zip":"1200","country":"Belgium","geoPoint":{"lat":50.85045,"lon":4.34878}},{"facility":"Universitair Ziekenhuis Antwerpen (UZA)","city":"Ghent","zip":"9000","country":"Belgium","geoPoint":{"lat":51.05,"lon":3.71667}},{"facility":"University Hospital Ghent","city":"Ghent","zip":"9000","country":"Belgium","geoPoint":{"lat":51.05,"lon":3.71667}},{"facility":"Hospital das Clinicas da UFMG","city":"Belo Horizonte","zip":"30140-080","country":"Brazil","geoPoint":{"lat":-19.92083,"lon":-43.93778}},{"facility":"Hospital Das Clinicas Da Ufg","city":"Goiânia","zip":"74535-170","country":"Brazil","geoPoint":{"lat":-16.67861,"lon":-49.25389}},{"facility":"Hospital de Clinicas de Porto Alegre","city":"Porto Alegre","zip":"90035-903","country":"Brazil","geoPoint":{"lat":-30.03283,"lon":-51.23019}},{"facility":"Escola Bahiana de Medicina e Saude Publica","city":"Salvador","zip":"40290-000","country":"Brazil","geoPoint":{"lat":-12.97563,"lon":-38.49096}},{"facility":"Hospital do Rim e Hipertensao","city":"São Paulo","zip":"04038-002","country":"Brazil","geoPoint":{"lat":-23.5475,"lon":-46.63611}},{"facility":"University of Alberta","city":"Edmonton","state":"Alberta","zip":"T6G 2R3","country":"Canada","geoPoint":{"lat":53.55014,"lon":-113.46871}},{"facility":"McMaster University Hospital","city":"Hamilton","state":"Ontario","zip":"L8L 0A4","country":"Canada","geoPoint":{"lat":43.25011,"lon":-79.84963}},{"facility":"The Ottawa Hospital - General Campus","city":"Ottawa","state":"Ontario","country":"Canada","geoPoint":{"lat":45.41117,"lon":-75.69812}},{"facility":"University Health Network - Toronto General Hospital","city":"Toronto","state":"Ontario","zip":"M5G 2C4","country":"Canada","geoPoint":{"lat":43.70643,"lon":-79.39864}},{"facility":"University of Calgary","city":"Calgary","zip":"T2N 4Z6","country":"Canada","geoPoint":{"lat":51.05011,"lon":-114.08529}},{"facility":"London Health Sciences Centre University Hospital","city":"London","zip":"N6A 5A5","country":"Canada","geoPoint":{"lat":42.98339,"lon":-81.23304}},{"facility":"McGill University Health Centre - Royal Victoria Hospital","city":"Montreal","zip":"H4A 3J1","country":"Canada","geoPoint":{"lat":45.50884,"lon":-73.58781}},{"facility":"Centre Hospitalier Universitaire Grenoble Alpes (CHU Grenoble Alpes)","city":"Grenoble","zip":"38043","country":"France","geoPoint":{"lat":45.17869,"lon":5.71479}},{"facility":"Centre Hospitalier Universitaire De Lille","city":"Lille","zip":"59037","country":"France","geoPoint":{"lat":50.63391,"lon":3.05512}},{"facility":"APHP-Hôpital Saint Antoine","city":"Paris","zip":"75571","country":"France","geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"CHU Bordeaux - Haut Lévêque","city":"Pessac","zip":"33600","country":"France","geoPoint":{"lat":44.80565,"lon":-0.6324}},{"facility":"Hannover Medical School","city":"Hanover","state":"Lower Saxony","zip":"30625","country":"Germany","geoPoint":{"lat":52.37052,"lon":9.73322}},{"facility":"Universitaetsklinikum Bonn","city":"Bonn","state":"Nordrhine-Westphalia","zip":"53127","country":"Germany","geoPoint":{"lat":50.73438,"lon":7.09549}},{"facility":"Charité Universtitätsmedizin - Campus Virchow-Klinikum","city":"Berlin","zip":"13353","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"Universitaetsklinikum Erlangen","city":"Erlangen","zip":"91054","country":"Germany","geoPoint":{"lat":49.59099,"lon":11.00783}},{"facility":"Universitätsklinikum Schleswig-Holstein - Campus Kiel","city":"Kiel","zip":"24105","country":"Germany","geoPoint":{"lat":54.32133,"lon":10.13489}},{"facility":"Universitatsklinikum Leipzig","city":"Leipzig","zip":"04103","country":"Germany","geoPoint":{"lat":51.33962,"lon":12.37129}},{"facility":"Otto-von-Guericke-Universitat Magdeburg","city":"Magdeburg","zip":"39120","country":"Germany","geoPoint":{"lat":52.13129,"lon":11.63189}},{"facility":"University Hospital Tubingen Medical Clinic","city":"Tübingen","zip":"72076","country":"Germany","geoPoint":{"lat":48.52266,"lon":9.05222}},{"facility":"St. Josefs-Hospital Wiesbaden","city":"Wiesbaden","zip":"65189","country":"Germany","geoPoint":{"lat":50.08601,"lon":8.24435}},{"facility":"Hillel Yaffe Medical Center","city":"Hadera","zip":"38100","country":"Israel","geoPoint":{"lat":32.44192,"lon":34.9039}},{"facility":"Rambam Medical Center","city":"Haifa","zip":"3109601","country":"Israel","geoPoint":{"lat":32.81303,"lon":34.99928}},{"facility":"Carmel Medical Center","city":"Haifa","zip":"3434104","country":"Israel","geoPoint":{"lat":32.81303,"lon":34.99928}},{"facility":"Shaare Zedek Medical Center","city":"Jerusalem","zip":"9103102","country":"Israel","geoPoint":{"lat":31.76904,"lon":35.21633}},{"facility":"Hadassah Medical Center - Ein Karem","city":"Jerusalem","zip":"91120","country":"Israel","geoPoint":{"lat":31.76904,"lon":35.21633}},{"facility":"Galilee Medical Center","city":"Nahariya","zip":"2210001","country":"Israel","geoPoint":{"lat":33.00892,"lon":35.09814}},{"facility":"Rabin Medical Center","city":"Petah Tikva","zip":"4941492","country":"Israel","geoPoint":{"lat":32.08707,"lon":34.88747}},{"facility":"Sheba Medical Center","city":"Ramat Gan","zip":"52621","country":"Israel","geoPoint":{"lat":32.08227,"lon":34.81065}},{"facility":"Tel Aviv Sourasky Medical Center","city":"Tel Aviv","zip":"6423906","country":"Israel","geoPoint":{"lat":32.08088,"lon":34.78057}},{"facility":"Azienda Ospedaliero-Universitaria di Bologna - Policlinico S. Orsola-Malpighi","city":"Bologna","zip":"40138","country":"Italy","geoPoint":{"lat":44.49381,"lon":11.33875}},{"facility":"Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico","city":"Milan","zip":"20122","country":"Italy","geoPoint":{"lat":45.46427,"lon":9.18951}},{"facility":"ASST Grande Ospedale Metropolitano Niguarda","city":"Milan","zip":"20162","country":"Italy","geoPoint":{"lat":45.46427,"lon":9.18951}},{"facility":"Fondazione IRCCS San Gerardo dei Tintori","city":"Monza","zip":"20900","country":"Italy","geoPoint":{"lat":45.58005,"lon":9.27246}},{"facility":"A.O.U. Federico II","city":"Napoli","zip":"80131","country":"Italy","geoPoint":{"lat":40.87618,"lon":14.5195}},{"facility":"Azienda Ospedale Universita Padova","city":"Padua","zip":"35100","country":"Italy","geoPoint":{"lat":45.40797,"lon":11.88586}},{"facility":"Amsterdam UMC - VU Medisch Centrum (VUmc)","city":"Amsterdam","zip":"1081 HV","country":"Netherlands","geoPoint":{"lat":52.37403,"lon":4.88969}},{"facility":"Universitair Medisch Centrum Groningen","city":"Groningen","zip":"9713 GZ","country":"Netherlands","geoPoint":{"lat":53.21917,"lon":6.56667}},{"facility":"Radboud University Medical Centre (MC)","city":"Nijmegen","zip":"6525 GA","country":"Netherlands","geoPoint":{"lat":51.8425,"lon":5.85278}},{"facility":"Erasmus University Medical Center","city":"Rotterdam","zip":"3015 GD","country":"Netherlands","geoPoint":{"lat":51.9225,"lon":4.47917}},{"facility":"Hospital Clinic Barcelona","city":"Barcelona","zip":"08036","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hospital General Universitario Gregorio Maranon","city":"Madrid","zip":"28007","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"University Hospital Zurich","city":"Zurich","zip":"8091","country":"Switzerland","geoPoint":{"lat":47.36667,"lon":8.55}},{"facility":"Royal Free Hospital","city":"London","state":"Hampstead","zip":"NW3 2QG","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"John Radcliffe Hospital","city":"Oxford","state":"Headington","zip":"OX3 9DU","country":"United Kingdom","geoPoint":{"lat":51.75222,"lon":-1.25596}},{"facility":"Royal Victoria Hospital","city":"Belfast","zip":"BT12 6BA","country":"United Kingdom","geoPoint":{"lat":54.59682,"lon":-5.92541}},{"facility":"University Hospitals Birmingham NHS Foundation Trust - Wellcome Trust Birmingham Clinical Research Facility","city":"Birmingham","zip":"B15 2TH","country":"United Kingdom","geoPoint":{"lat":52.48142,"lon":-1.89983}},{"facility":"Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital","city":"Cambridge","zip":"CB2 0QQ","country":"United Kingdom","geoPoint":{"lat":52.2,"lon":0.11667}},{"facility":"Lothian NHS Board","city":"Edinburgh","zip":"EH164SA","country":"United Kingdom","geoPoint":{"lat":55.95206,"lon":-3.19648}},{"facility":"St James' University Hospital Leeds Teaching Hospitals NHS Trust","city":"Leeds","zip":"LS9 7TF","country":"United Kingdom","geoPoint":{"lat":53.79648,"lon":-1.54785}},{"facility":"King's College Hospital NHS Foundation Trust","city":"London","zip":"SE5 9RS","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"The Newcastle upon Tyne Hospitals NHS Foundation Trust - Royal Victoria Infirmary","city":"Newcastle upon Tyne","zip":"NE1 4LP","country":"United Kingdom","geoPoint":{"lat":54.97328,"lon":-1.61396}},{"facility":"Nottingham University Hospital NHS Trust","city":"Nottingham","zip":"NG7 2FT","country":"United Kingdom","geoPoint":{"lat":52.9536,"lon":-1.15047}},{"facility":"University Hospital Southampton NHS Foundation Trust","city":"Southampton","country":"United Kingdom","geoPoint":{"lat":50.90395,"lon":-1.40428}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-02-25"},"conditionBrowseModule":{"meshes":[{"id":"D015209","term":"Cholangitis, Sclerosing"},{"id":"D011537","term":"Pruritus"},{"id":"D002779","term":"Cholestasis"}],"ancestors":[{"id":"D002761","term":"Cholangitis"},{"id":"D001649","term":"Bile Duct Diseases"},{"id":"D001660","term":"Biliary Tract Diseases"},{"id":"D004066","term":"Digestive System Diseases"},{"id":"D012871","term":"Skin Diseases"},{"id":"D017437","term":"Skin and Connective Tissue Diseases"},{"id":"D012877","term":"Skin Manifestations"},{"id":"D012816","term":"Signs and Symptoms"},{"id":"D013568","term":"Pathological Conditions, Signs and Symptoms"}]},"interventionBrowseModule":{"meshes":[{"id":"C000627853","term":"volixibat"}]}},"hasResults":false}
]}